Opus Genetics, Inc. (IRD) stock
IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.05+0.01 (+0.25%)
Close on Nov 17, 2026Market cap $336.94MP/E –Yield –
Opus Genetics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Opus Genetics's operating cash flow for the twelve months ending Jun 30, 2026 was -$40.67M. For fiscal 2025 it was -$35.25M. The highest annual figure on record is $14.31M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$35.25M | – |
| FY2024 | Dec 31, 2024 | -$25.58M | – |
| FY2023 | Dec 31, 2023 | -$1.11M | -107.8% |
| FY2022 | Dec 31, 2022 | $14.31M | – |
| FY2021 | Dec 31, 2021 | -$19.37M | – |
| FY2020 | Dec 31, 2020 | -$6.80M | – |
| FY2019 | Dec 31, 2019 | -$3.59M | – |
| FY2018 | Dec 31, 2018 | -$18.84M | – |
| FY2017 | Dec 31, 2017 | -$15.42M | – |
| FY2016 | Dec 31, 2016 | -$13.23M | – |
| FY2015 | Dec 31, 2015 | -$17.35M | – |
| FY2014 | Dec 31, 2014 | -$11.04M | – |
| FY2013 | Dec 31, 2013 | -$7.98M | – |
| FY2012 | Dec 31, 2012 | -$6.62M | – |
| FY2011 | Dec 31, 2011 | -$15.53M | – |
| FY2010 | Dec 31, 2010 | -$6.99M | – |
| FY2009 | Dec 31, 2009 | -$5.15M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.95M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.73M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.83M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.16M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.27M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.99M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.44M | -263.5% |
| Q3 FY2024 | Sep 30, 2024 | -$5.13M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.29M | -837.3% |
| Q1 FY2024 | Mar 31, 2024 | -$5.72M | – |
| Q4 FY2023 | Dec 31, 2023 | $4.55M | -84.2% |
| Q3 FY2023 | Sep 30, 2023 | -$3.00M | – |
| Q2 FY2023 | Jun 30, 2023 | $989.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.65M | – |
| Q4 FY2022 | Dec 31, 2022 | $28.79M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.50M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.81M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.17M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.65M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.33M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.81M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.36M | -187.7% |
| Q3 FY2020 | Sep 30, 2020 | -$1.06M | – |
| Q2 FY2020 | Jun 30, 2020 | -$651.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$732.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $4.97M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.38M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.81M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.38M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.62M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.17M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.45M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.60M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.70M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.45M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.10M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.17M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.49M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.12M | – |
See a number that looks wrong?